Tax and Accounting Considerations
In matters of style, swim with the current. In matters of principle, stand like a rock.
Teva Pharmaceutical Industries, a manufacturer and distributor of generic drugs, completed its takeover of Ivax Corp for $7.4 billion in early 2006 to become the world's largest manufacturer of generic drugs. For Teva, based in Israel, and Ivax, headquartered in Miami, the merger eliminated a large competitor and created a distribution chain that spans 50 countries.
To broaden the appeal of the proposed merger, Teva offered Ivax shareholders the option to receive for each of their shares either 0.8471 ...